REG - Eco Animal Health Gp - Board Appointment

ECO Animal HealthAnnouncement

01/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211201:nRSA1112Ua&default-theme=true

RNS Number : 1112U  Eco Animal Health Group PLC  01 December 2021

1 December 2021

 

ECO Animal Health Group plc

 

("ECO" or the "Company") (AIM: EAH)

 

Board Appointment

 

 

ECO Animal Health Group plc, a leader in the development, registration and
marketing of pharmaceutical products for global animal health market, is
pleased to announce the appointment of Tracey James as a Non-Executive
Director with immediate effect.

Tracey is a Chartered Accountant who has spent 26 years with Grant Thornton UK
LLP, with the last 14 years as an Audit Partner. Tracey was a member of Grant
Thornton's Oversight Board and also served on the Audit & Risk and
Pensions Committees. She was also previously Finance Director of Karl Storz
Endoscopy Canada (1999-2000). Tracey is currently a Non-Executive Director and
Chair of the Audit Committee at specialist Engineering and Technology
recruitment solutions business, Gattaca plc.

Tracey will join the Audit Committee of ECO.

Commenting on the appointment Andrew Jones, Chairman, said:

"I am delighted to welcome Tracey to the ECO Board. She has a strong financial
background at senior level in Grant Thornton and brings with her a wealth of
experience of growing businesses and AIM-listed companies."

 

Additional Information on the Board Appointment:

 

The following additional information is provided with regards to the
appointment of Tracey Dawn James (née Clements), aged 58, in accordance with
AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

Current directorships/partnerships:

 

Gattaca plc

 

Directorships/partnerships within the last five years:

 

Activate Learning Group (Charity)

Allenbuild Limited

Grant Thornton UK LLP

Millwood Designer Homes Limited

Modularwise Limited

Places for People Developments Limited

Places for People Group Limited

Places for People Ventures Limited

Places for People Ventures Operations Limited

Zeroc Group (2008) Limited

 

 

There are no further disclosures required to be made in respect of the
appointment under AIM Rule 17 and Schedule 2(g) of the AIM Rules for
Companies.

 

Contacts:

                                                                020 8447 6906

 ECO Animal Health Group plc

 Marc Loomes (CEO)

 Christopher Wilks (CFO)

 IFC Advisory                                                   020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Mark Taylor

 George Tzimas

 Peel Hunt LLP (Joint Broker)                                   020 7418 8900

 James Steel

 Dr Christopher Golden

 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans

 

 

About ECO Animal Health

 

ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and
commercialises products for livestock. Our business strategy is to generate
shareholder value by achieving the maximum sales potential from the existing
product portfolio whilst investing in Research and Development ("R&D") for
new products, particularly vaccines, and seeking to in-license new products

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGZMFMRGKGMZM